Target intelligence / Profile preview

Transmembrane protein 111 pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

Transmembrane protein 111 pseudogene (ENSG00000261527) is a non-coding genetic sequence classified as a pseudogene; it corresponds to the gene for ER membrane protein complex subunit 3 (EMC3) but does not produce a functional protein. Pseudogenes are parts of the genome that resemble known genes but typically lack protein-coding ability due to disruptive mutations or incomplete transcription. They are not considered therapeutic targets, enzymes, receptors, transporters, or other conventional drug targets. No disease role, mechanism of action, or drug interaction is documented for this pseudogene. Its biological significance, if any, would be indirect, such as through regulation of the parental gene via competitive endogenous RNA mechanisms, but no evidence currently supports such a function for this particular pseudogene[5]. The term "pseudogene" means this entry does not encode a functional protein and lacks canonical roles in biochemical pathways[5]. EMC3, the true parent gene, is protein coding and is part of the ER membrane protein complex, involved in co- and post-translational insertion of multi-pass membrane proteins, but the pseudogene does not share these functions[4]. There is no record of interacting drugs, mechanisms of action, biomarker use, or safety concerns associated with this pseudogene, nor of it being classified as a therapeutic target[4][5]. The presence of this pseudogene should not be confused with EMC3 or other protein-coding transmembrane proteins that are genuine drug targets or molecular receptors. The designation "transmembrane protein 111 pseudogene" may mislead users into thinking it is a functional membrane protein or receptor; strictly, it is not.

Other names
ER membrane protein complex subunit 3 pseudogeneLOC100420066

Beyond the preview

Go deeper on Transmembrane protein 111 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 111 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call